May 7, 2018 Portfolio News from ARCH Venture Partners | Share Unity Biotechnology, Inc. Announces Closing of Initial Public Offering
May 2, 2018 Portfolio News from ARCH Venture Partners | Share insitro: Rethinking drug discovery using machine learning
April 17, 2018 Portfolio News from ARCH Venture Partners | Share GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection
April 3, 2018 Media Coverage from ARCH Venture Partners | Share Robert Nelsen named #5 on Forbes Midas List 2018
March 27, 2018 Portfolio News from ARCH Venture Partners | Share Hua Medicine Raises $117.4 Million in Series D & Series E Financing
March 19, 2018 Portfolio News from ARCH Venture Partners | Share UNITY Biotechnology, Inc. Completes $55 Million Series C Financing
March 15, 2018 Portfolio News from ARCH Venture Partners | Share Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform
January 22, 2018 Portfolio News from ARCH Venture Partners | Share Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
January 4, 2018 Portfolio News from ARCH Venture Partners | Share Former Receptos Executives Launch Gossamer Bio, Inc., a New Biopharma Company Focused on Discovering and Developing a Pipeline of Novel and Differentiated Drug Candidates
December 11, 2017 Portfolio News from ARCH Venture Partners | Share Quanterix Corporation Announces Closing of Initial Public Offering
December 4, 2017 Portfolio News from ARCH Venture Partners | Share Denali Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares
